首页|Inducing mitochondriopathy-like damages by transformable nucleopeptide nanoparticles for targeted therapy of bladder cancer

Inducing mitochondriopathy-like damages by transformable nucleopeptide nanoparticles for targeted therapy of bladder cancer

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
Mitochondriopathy inspired adenosine triphosphate(ATP)depletions have been recognized as a powerful way for controlling tumor growth.Nevertheless,selective sequestration or exhaustion of ATP under complex biological environments remains a prodigious challenge.Harnessing the advantages of in vivo self-assembled nanomaterials,we designed an Intracellular ATP Sequestration(IAS)system to specifically construct nanofibrous nanostructures on the surface of tumor nuclei with exposed ATP binding sites,leading to highly efficient suppression of bladder cancer by induction of mitochondriopathy-like damages.Briefly,the reported transformable nucleopeptide(NLS-FF-T)self-assembled into nuclear-targeted nanoparticles with ATP binding sites encapsulated inside under aqueous conditions.By interaction with KPNA2,the NLS-FF-T transformed into a nanofibrous-based ATP trapper on the surface of tumor nuclei,which prevented the production of intracellular energy.As a result,multiple bladder tumor cell lines(T24,EJ and RT-112)revealed that the half-maximal inhibitory concentration(IC50)of NLS-FF-T was reduced by approximately 4-fold when compared to NLS-T.Following intravenous administration,NLS-FF-T was found to be dose-dependently accumulated at the tumor site of T24 xenograft mice.More significantly,this IAS system exhibited an extremely antitumor efficacy according to the deterioration of T24 tumors and simultaneously prolonged the overall survival of T24 orthotopic xenograft mice.Together,our findings clearly demonstrated the therapeutic advantages of intracellular ATP sequestration-induced mitochondriopathy-like damages,which provides a potential treatment strategy for malignancies.

self-assemblynucleopeptidenanomaterialbladder cancermitochondriopathy

Da-Yong Hou、Ni-Yuan Zhang、Lu Wang、Mei-Yu Lv、Xiang-Peng Li、Peng Zhang、Yue-Ze Wang、Lei Shen、Xiu-Hai Wu、Bo Fu、Peng-Yu Guo、Zi-Qi Wang、Dong-Bing Cheng、Hao Wang、Wanhai Xu

展开 >

NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics,Heilongjiang Key Laboratory of Scientific Research in Urology,Harbin Medical University,Harbin 150001,China

Department of Urology,Harbin Medical University Cancer Hospital,Harbin 150001,China

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety,CAS Center for Excellence in Nanoscience,National Center for Nanoscience and Technology(NCNST),Beijing 100190,China

School of Chemistry,Chemical Engineering & Life Science,Hubei Key Laboratory of Nanomedicine for Neurodegenerative Diseases,Wuhan University of Technology,Wuhan 430070,China

展开 >

国家重点研发计划Regional Key Project of National Natural Science Foundation of ChinaOverseas Highend Talents Introduction Program国家自然科学基金国家自然科学基金国家自然科学基金Heilongjiang Province Key Research and Development Program

2021YFB3801000U20A20385G2022011023L8230226682171999820026882022XJ03C07

2024

10.1093/nsr/nwae028

国家科学评论(英文版)

国家科学评论(英文版)

CSTPCD
ISSN：
年,卷(期)：2024.11(4)
  • 49